Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
29 April 2024 - P2822
Emergence of invasive infections due to the rare yeast Trichosporon austroamericanum sp. nov. (formerly T. inkin sensu lato) in patients undergoing cardio-vascular surgery in three European countries
Anne-Cecile Normand, Marion Blaize, Marie Desnos-Ollivier, Valérie Goldstein, Pascal Leprince, Guillaume Lebreton, Romain Mahieu, Adrien Bouglé, Charles-Edouard Luyt, Cécile Nabet, Arnaud Jabet, Christine Bonnal, Solen Kernéis, Tiphaine Goulenok, Sébastien Imbert, Isabel Sanchez Romero, Ravi Vazirani Ballesteros, Françoise Botterel, Boualem Sendid, Narivanh Forest, Delphine Martiny, Elodie De Groote, Jérôme Robert, Sandra Fournier, Oscar Zaragoza, Ann Packeu, Fanny Lanternier, Renaud Piarroux, Arnaud Fekkar
28 April 2024 - P2455
Addition of urine NGAL to serum creatinine improves prediction of cefepime clearance in pediatric ICU patients at high risk of acute kidney injury
Horace Rhodes Hambrick, Michaela Collins, Kelli Krallman, Tomoyuki Mizuno, Stuart L. Goldstein, Sonya Tang Girdwood
28 April 2024 - O0687
BPZE1, an intranasal live attenuated pertussis vaccine, evaluated in a Bordetella pertussis challenge study in healthy adults: a Phase IIb, randomised, placebo-controlled study
Diane Gbesemete, Maheshi Ramasamy, Muktar Ibrahim, Alison Hill, Lucy Raud, Daniela Ferreira, Jonathan Guy, Adam Dale, Jay Laver, Tyween Coutinho, Lisa Weissfeld, Wei Lang, Camille Locht, Vivek Samal, Peter Goldstein, Ken Solovay, Keith Rubin, Stephanie Noviello, Robert Read
17 April 2023 - P2671
Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe COVID-19
Avigayil Goldstein, Ami Neuberger, Yazeed Qassem Darawsha, Tali Shafat, Daniel Grupel, Sarah Israel, Ariel Weil, Ronen Ben-Ami, Meital Elbaz, Ronza Najjar-Debbiny, Jihad Bishara, Amir Shlomai, Michal Landes
16 April 2019 - O1059
Safety and immunogenicity of a 2-dose Ebola vaccine regimen with Ad26.ZEBOV and MVA-BN-Filo in a Phase III clinical trial in Sierra Leone
Bailah Leigh, David Ishola, Daniela Manno, Kwanbena Owusi-Kyei, Muhammed Afolabi, Frank Baiden, Neil Goldstein, Cynthia Robinson, Mohamed Samai, Auguste Gaddah, Viki Bockstal, Ken Awuondo, Brett Lowe, Brian Greenwood, Maarten Leyssen, Deborah Watson-Jones, Macaya Douoguih
15 April 2019 - P2100
The key role of the clinical pharmacist in improving gentamicin use in a teaching hospital
Bibiana Chazan, Hiba Akel, Tarek Artoul, Anna Yanovskay, Lee Goldstein
14 April 2019 - P1320
Systematic genomic analysis of NDM-producing Enterobacteriaceae during an outbreak in a French university hospital
Stéphane LO, Valérie Goldstein, Emilie Rondinaud, Etienne Ruppé, Isabelle Lolom, Marie Petitjean, Jean-Christophe Lucet, Camille D'Humieres, Laurence Armand-Lefevre
13 April 2019 - P0398
Anamnestic response after antigen re-exposure following Ebola vaccine regimen with Ad26.ZEBOV and MVA-BN-Filo in a phase I study
Viki Bockstal, Neil Goldstein, Cynthia Robinson, Auguste Gaddah, Ramon Roozendaal, Kerstin Luhn, Stephan Bart, Macaya Douoguih
13 April 2019 - P0399
Safety and immunogenicity of 2-dose Ebola vaccine regimen with Ad26.ZEBOV and MVA-BN-Filo in a phase II clinical trial in Europe (EBOVAC2)
Viki Bockstal, Rodolphe Thiebaut, Matthew D Snape, Neil Goldstein, Cynthia Robinson, Auguste Gaddah, Odile Launay, Jean-Daniel Lelievre, Laura Richert, Christine Betard, Andrew Pollard, Malick Gibani, Elizabeth Clutterbuck, Maarten Leyssen, Kerstin Luhn, Macaya Douoguih
23 April 2018 - P1673
In vitro activity of ceftazidime alone and in combination with SPR741 against anaerobic bacteria
Aileen Rubio, D. Citron, K. Tyrrell, A. Rubio, E. Goldstein
25 April 2017 - OS0978
Monovalent and multivalent heterologous prime-boost filovirus vaccines: response to the West African Ebola outbreak and preparedness for the future
Valerie Oriol Mathieu, Cynthia Robinson, Georgi Shukarev, Neil Goldstein, Kerstin Luhn, Peter Tjeerdsma, Carlo Van Wordragen, Ramon Roozendaal, Simone Spreng, Macaya Douoguih, Benoit Callendret
10 April 2016 - P0603
Antimicrobial susceptibility of Clostridium difficile 027-related ribotypes 176, 198 and 244 recovered during MODIFY I and MODIFY II clinical trials conducted between 2012 and 2014
Diane M. Citron, Citron Diane M., Zatorska Beata, D. Citron, S. Sambol, S. Johnson, E. Best, M. Wilcox, M. Dorr, E. Goldstein
11 May 2014 - P0801
SMT 19969: a novel agent for Clostridium difficile infection - summary results from in vitro microbiology and a randomised double blind phase 1 clinical trial
Richard Vickers, Vickers, R. J.(1)*; Citron, D.M.(2); Goldstein, E.J.C.(2); Best, E. L.(3); Wilcox, M.H.(3);
28 April 2013 - P1624
In vitro activities of ceftaroline and ceftaroline-avibactam against aerobic and anaerobic bacteria recovered from diabetic foot infections
Diane M. Citron, D.M. Citron*, E.J.C. Goldstein (Culver City, US)
28 April 2013 - P1646
Dalbavancin activity in the USA: reported from the SENTRY Programme (2012)
Ronald N. Jones, R.N. Jones*, R.K. Flamm, H.S. Sader, B.P. Goldstein, M. Dunne (North Liberty, Morristown, US)
02 April 2012 - P1890
Dalbavancin maintains potent in vitro activity against S. aureus resistant to currently utilised anti-MRSA therapeutics
Jennifer Deane, D.F. Sahm*, J. Deane, B.P. Goldstein, M. Dunne (Chantilly, Morristown, US)
31 March 2012 - R2518
More than a Gram-positive agent: in vitro activity of dalbavancin against Moraxella catarrhalis
Laura Koeth, L. Koeth*, A. Windau, B. Goldstein (Westlake, Sheffield, Wayne, US)
19 April 2008
US Survey on Resistance Among the Bacteroides Species for 2005-2007
Snydman, D., Jacobus, N.V., McDermott, L.A., Golan, Y., Hecht D.W., Goldstein, E.J.C., Harrell, L., Jenkins, S., Newton, Pierson, C., Rihs, J., Rosenblatt, Venezia, R., Yu, V.L., and Gorbach, S.L.
01 April 2006
Comparison of dalbavancin MIC values tested against Gram-positive organisms using E-test (AB BIODISK) and reference dilution methods
T. Fritsche, H. Sader, R. Jones, B. Goldstein
01 April 2006
Efficacy of anidulafungin against Candida albicans in candidaemia and other forms of invasive candidiasis
B. Goldstein, B. Johnson, W. Wible, D.S. Krause, H. Schlamm
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.